Company: HURA
Filing Date: 2025-11-04
Form Type: 8-K
Source: 0001193125-25-263523
Chunk: 2

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-04
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                                                                       
         10.1      At The Market Offering Agreement, dated November 3, 2025, between TuHURA Biosciences, Inc. and H. C. Wainwright & Co., LLC (incorporated by reference to Exhibit  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

           1.2 to the Registration Statement on Form S-3 filed by the Company on November 3, 2025)  
 ────────────────────────────────────────────────────────────────────────────────────────────────────
  104      Cover Page Interactive Data File (embedded within the Inline XBRL document).             

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                            TUHURA BIOSCIENCES, INC.        
  Date:      November 4, 2025      By:      /s/ Dan Dearborn                
                                            Name: Dan Dearborn